PharmaResearch Co., Ltd. received clearance from the U.S. Food and Drug Administration to begin a Phase 1 clinical trial of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE